Herbal Composition PC-SPES for Management of Prostate Cancer: Identification of Active Principles
Sovak, Milos, Seligson, Allen L., Konas, Martin, Hajduch, Marian, Dolezal, Marek, Machala, Miroslav, Nagourney, Robert
Published in JNCI : Journal of the National Cancer Institute (04.09.2002)
Published in JNCI : Journal of the National Cancer Institute (04.09.2002)
Get full text
Journal Article
Late-Breaking Abstract 5: Results from a 2nd interim OS analysis in OCEANS: A randomized phase 3 trial of gemcitabine (G), carboplatin (C) and bevacizumab (BV) followed by BV to disease progression in patients with platinum-sensitive recurrent epithelial ovarian (OC), primary peritoneal (PPC), or fallopian tube cancer (FTC)
Aghajanian, C, Blank, S, Goff, B, Judson, P, Nycum, L, Sovak, M, Yi, J, Husain, A
Published in Gynecologic oncology (01.06.2012)
Published in Gynecologic oncology (01.06.2012)
Get full text
Journal Article
Independent radiologic review of OCEANS, a phase III trial of carboplatin, gemcitabine, and bevacizumab or placebo for the treatment of platinum-sensitive, recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer
Aghajanian, C, Makhija, S, Rutherford, T, Sharma, S, Nycum, L, Sovak, M, Nguyen, H, Yi, J, Husain, A
Published in Gynecologic oncology (01.03.2012)
Published in Gynecologic oncology (01.03.2012)
Get full text
Journal Article
Paclitaxel and carboplatin in the treatment of advanced or recurrent endometrial cancer: a large retrospective study
Sovak, M A, Dupont, J, Hensley, M L, Ishill, N, Gerst, S, Abu-Rustum, N, Anderson, S, Barakat, R, Konner, J, Poyner, E, Sabbatini, P, Spriggs, D R, Aghajanian, C
Published in International journal of gynecological cancer (01.01.2007)
Published in International journal of gynecological cancer (01.01.2007)
Get full text
Journal Article
Activation of NF-κB/Rel occurs early during neoplastic transformation of mammary cells
Kim, Dong W., Sovak, Mika A., Zanieski, Gregory, Nonet, Genevieve, Romieu-Mourez, Raphaëlle, Lau, Alan W., Hafer, Laurie J., Yaswen, Paul, Stampfer, Martha, Rogers, Adrianne E., Russo, Jose, Sonenshein, Gail E.
Published in Carcinogenesis (New York) (01.05.2000)
Published in Carcinogenesis (New York) (01.05.2000)
Get full text
Journal Article
411 POSTER A phase I, open-label, dose-escalation study of the safety and pharmacology of MetMAb, a monovalent antagonist antibody to the receptor c-Met, administered IV in patients with locally advanced or metastatic solid tumors
Salgia, R, Peterson, A, Eppler, S, Yu, W, Polite, B, Geary, D, Wesolowski, E, LaRosiliere, M, Ratain, M, Sovak, M
Published in European journal of cancer supplements (2008)
Published in European journal of cancer supplements (2008)
Get full text
Journal Article
Contrast media as carriers for local drug delivery: Successful inhibition of neointimal proliferation in the porcine coronary stent model
SCHELLER, Bruno, SPECK, Ulrich, ROMEIKE, Bernd, SCHMITT, Alexander, SOVAK, Milos, BÖHM, Michael, STOLL, Hans-Peter
Published in European heart journal (01.08.2003)
Published in European heart journal (01.08.2003)
Get full text
Journal Article
Independent radiologic review of GOG218, a phase III trial of bevacizumab (BEV) in the primary treatment of advanced epithelial ovarian (EOC), primary peritoneal (PPC) or Fallopian tube cancer (FTC)
Burger, R. A., Brady, M. F., Rhee, J., Sovak, M. A., Nguyen, H., Bookman, M. A.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Exploration of the functional significance of the stilbene disulfonate binding site in mouse band 3 by site-directed mutagenesis
Passow, H., Wood, P.G., Lepke, S., Müller, H., Sovak, M.
Published in Biophysical journal (01.04.1992)
Published in Biophysical journal (01.04.1992)
Get full text
Journal Article
198P - Biomarker (BM) Results from GOG-0218, a Phase 3 Trial of Front-Line Bevacizumab (BV) + Chemotherapy (CT) for Ovarian Cancer (OC)
Birrer, M.J., Lankes, H., Burger, R.A., Mannel, R., Homesley, H., Henschel, V., Sovak, M., Scherer, S.J., de Haas, S., Pallaud, C.
Published in Annals of oncology (01.09.2012)
Published in Annals of oncology (01.09.2012)
Get full text
Journal Article
Biomarker (BM) Results from GOG-0218, a Phase 3 Trial of Front-Line Bevacizumab (BV) + Chemotherapy (CT) for Ovarian Cancer (OC)
Birrer, M.J., Lankes, H., Burger, R.A., Mannel, R., Homesley, H., Henschel, V., Sovak, M., Scherer, S.J., de Haas, S., Pallaud, C.
Published in Annals of oncology (01.09.2012)
Published in Annals of oncology (01.09.2012)
Get full text
Journal Article
OCEANS: A randomized, double-blinded, placebo-controlled phase III trial of chemotherapy with or without bevacizumab (BEV) in patients with platinum-sensitive recurrent epithelial ovarian (EOC), primary peritoneal (PPC), or fallopian tube cancer (FTC)
Aghajanian, C., Finkler, N. J., Rutherford, T., Smith, D. A., Yi, J., Parmar, H., Nycum, L. R., Sovak, M. A.
Published in Journal of clinical oncology (20.06.2011)
Published in Journal of clinical oncology (20.06.2011)
Get full text
Journal Article
OCEANS: A randomized, double-blinded, placebo-controlled phase III trial of chemotherapy with or without bevacizumab (BEV) in patients with platinum-sensitive recurrent epithelial ovarian (EOC), primary peritoneal (PPC), or fallopian tube cancer (FTC)
Aghajanian, C., Finkler, N. J., Rutherford, T., Smith, D. A., Yi, J., Parmar, H., Nycum, L. R., Sovak, M. A.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article